313 related articles for article (PubMed ID: 22050954)
1. Cell-derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation?
Baron M; Boulanger CM; Staels B; Tailleux A
J Cell Mol Med; 2012 Jul; 16(7):1365-76. PubMed ID: 22050954
[TBL] [Abstract][Full Text] [Related]
2. Circulating cell-derived microparticles as biomarkers in cardiovascular disease.
Thulin Å; Christersson C; Alfredsson J; Siegbahn A
Biomark Med; 2016 Sep; 10(9):1009-22. PubMed ID: 27586235
[TBL] [Abstract][Full Text] [Related]
3. Microparticles as new markers of cardiovascular risk in diabetes and beyond.
Santilli F; Marchisio M; Lanuti P; Boccatonda A; Miscia S; Davì G
Thromb Haemost; 2016 Aug; 116(2):220-34. PubMed ID: 27173919
[TBL] [Abstract][Full Text] [Related]
4. Microparticles during long-term follow-up after acute myocardial infarction. Association to atherosclerotic burden and risk of cardiovascular events.
Christersson C; Thulin Å; Siegbahn A
Thromb Haemost; 2017 Jul; 117(8):1571-1581. PubMed ID: 28424820
[TBL] [Abstract][Full Text] [Related]
5. Increased microparticle levels in middle-aged and elderly patients with insomnia may be involved in the pathogenesis of arteriosclerosis.
Xu B; Ma L; Zhang N; Guo W; Luo LM; Wang C; Jiang Y; Liu LG
Int Angiol; 2020 Jun; 39(3):252-260. PubMed ID: 32052947
[TBL] [Abstract][Full Text] [Related]
6. Microparticles: targets and tools in cardiovascular disease.
Martinez MC; Tual-Chalot S; Leonetti D; Andriantsitohaina R
Trends Pharmacol Sci; 2011 Nov; 32(11):659-65. PubMed ID: 21794929
[TBL] [Abstract][Full Text] [Related]
7. Microparticles, vascular function, and atherothrombosis.
Rautou PE; Vion AC; Amabile N; Chironi G; Simon A; Tedgui A; Boulanger CM
Circ Res; 2011 Aug; 109(5):593-606. PubMed ID: 21852557
[TBL] [Abstract][Full Text] [Related]
8. Microparticles: a component of various diseases.
Budaj M; Poljak Z; Ďuriš I; Kaško M; Imrich R; Kopáni M; Maruščáková L; Hulín I
Pol Arch Med Wewn; 2012; 122 Suppl 1():24-9. PubMed ID: 23222474
[TBL] [Abstract][Full Text] [Related]
9. Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles?
Campello E; Radu CM; Duner E; Lombardi AM; Spiezia L; Bendo R; Ferrari S; Simioni P; Fabris F
Cytometry B Clin Cytom; 2018 Mar; 94(2):334-341. PubMed ID: 28052584
[TBL] [Abstract][Full Text] [Related]
10. The pattern of circulating microparticles in patients with diabetes mellitus with asymptomatic atherosclerosis.
Berezin AE; Kremzer AA; Berezina TA; Martovitskaya YV
Acta Clin Belg; 2016 Feb; 71(1):38-45. PubMed ID: 27075791
[TBL] [Abstract][Full Text] [Related]
11. Circulating microparticles as biomarkers of stroke: A focus on the value of endothelial- and platelet-derived microparticles.
El-Gamal H; Parray AS; Mir FA; Shuaib A; Agouni A
J Cell Physiol; 2019 Aug; 234(10):16739-16754. PubMed ID: 30912147
[TBL] [Abstract][Full Text] [Related]
12. The Role of Cell-derived Microparticles in Cardiovascular Diseases: Current Concepts.
Stampouloglou PK; Siasos G; Bletsa E; Oikonomou E; Vogiatzi G; Kalogeras K; Katsianos E; Vavuranakis MA; Souvaliotis N; Vavuranakis M
Curr Pharm Des; 2022; 28(21):1745-1757. PubMed ID: 35986552
[TBL] [Abstract][Full Text] [Related]
13. [Vascular dysfunction in obstructive sleep apnoea: Implication of microparticules].
Trzepizur W; Priou P; Meslier N; Urban T; Martínez MC; Andriantsitohaina R; Gagnadoux F
Rev Pneumol Clin; 2017 Dec; 73(6):306-308. PubMed ID: 29126756
[TBL] [Abstract][Full Text] [Related]
14. Cell-Derived Microparticles and Acute Coronary Syndromes: Is there a Predictive Role for Microparticles?
Zacharia E; Zacharias K; Papamikroulis GA; Bertsias D; Miliou A; Pallantza Z; Papageorgiou N; Tousoulis D
Curr Med Chem; 2020; 27(27):4440-4468. PubMed ID: 31838988
[TBL] [Abstract][Full Text] [Related]
15. High Level of Circulating Microparticles in Patients with BCR/ABL Negative Myeloproliferative Neoplasm - a Pilot Study.
Aswad MH; Kissová J; Rihova L; Zavrelova J; Ovesná P; Penka M
Klin Onkol; 2019; 32(2):109-116. PubMed ID: 30995850
[TBL] [Abstract][Full Text] [Related]
16. Relationship of microparticles to progenitor cells as a measure of vascular health in a diabetic population.
Curtis AM; Zhang L; Medenilla E; Gui M; Wilkinson PF; Hu E; Giri J; Doraiswamy V; Gunda S; Burgert ME; Moore JS; Edelberg JM; Mohler ER
Cytometry B Clin Cytom; 2010 Sep; 78(5):329-37. PubMed ID: 20544836
[TBL] [Abstract][Full Text] [Related]
17. Circulating endothelial cells and microparticles as diagnostic and prognostic biomarkers in small-cell lung cancer.
Najjar F; Alammar M; Al-Massarani G; Almalla N; Japawe A; Ikhtiar A
Lung Cancer; 2018 Oct; 124():23-30. PubMed ID: 30268466
[TBL] [Abstract][Full Text] [Related]
18. Microparticle and Atherothrombotic Diseases.
Nomura S
J Atheroscler Thromb; 2016; 23(1):1-9. PubMed ID: 26412494
[TBL] [Abstract][Full Text] [Related]
19. Microparticles: From Biogenesis to Biomarkers and Diagnostic Tools in Cardiovascular Disease.
Alexandru N; Costa A; Constantin A; Cochior D; Georgescu A
Curr Stem Cell Res Ther; 2017; 12(2):89-102. PubMed ID: 26647911
[TBL] [Abstract][Full Text] [Related]
20. Microparticles reveal cell activation during IVF - a possible early marker of a prothrombotic state during the first trimester.
Olausson N; Mobarrez F; Wallen H; Westerlund E; Hovatta O; Henriksson P
Thromb Haemost; 2016 Aug; 116(3):517-23. PubMed ID: 27412479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
